These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24602336)

  • 21. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.
    Silva MB; Andrade TM; Silva LK; Rodart IF; Lopes GB; Carmo TM; Zarife MA; Dourado I; Reis MG
    Mem Inst Oswaldo Cruz; 2010 May; 105(3):299-303. PubMed ID: 20512243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China.
    Zhang C; Wu N; Liu J; Ge Q; Huang Y; Ren Q; Feng Q; He G
    PLoS One; 2011 Feb; 6(2):e16817. PubMed ID: 21304823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hepatitis C infection among intravenous drug users in Shanghai.
    Tao YL; Tang YF; Qiu JP; Cai XF; Shen XT; Wang YX; Zhao XT
    World J Gastroenterol; 2013 Aug; 19(32):5320-5. PubMed ID: 23983436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
    Xia X; Luo J; Bai J; Yu R
    Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
    Morice Y; Cantaloube JF; Beaucourt S; Barbotte L; De Gendt S; Goncales FL; Butterworth L; Cooksley G; Gish RG; Beaugrand M; Fay F; Fay O; Gonzalez JE; Martins RM; Dhumeaux D; Vanderborght B; Stuyver L; Sablon E; de Lamballerie X; Pawlotsky JM
    J Med Virol; 2006 Oct; 78(10):1296-303. PubMed ID: 16927280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
    Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic variants of hepatitis C virus in HIV-infected drug users].
    Bobkova MR; Samokhvalov EI; Kravchenko AV; Salamov GG; Zverev SIa; Pokrovskiĭ VV; L'vov DK
    Vopr Virusol; 2002; 47(3):15-20. PubMed ID: 12173428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The seroprevalence of HCV among injecting drug users in the years 2004-2008 in Slovakia].
    Gazdíková K; Gazdík F; Kajaba I; Hučková D; Okruhlica L; Farkašová D
    Vnitr Lek; 2012 Mar; 58(3):179-82. PubMed ID: 22486282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
    Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
    J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan.
    Sanders-Buell E; Rutvisuttinunt W; Todd CS; Nasir A; Bradfield A; Lei E; Poltavee K; Savadsuk H; Kim JH; Scott PT; de Souza M; Tovanabutra S
    J Med Virol; 2013 Jul; 85(7):1170-9. PubMed ID: 23918535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.
    Zhang L; Chen Z; Cao Y; Yu J; Li G; Yu W; Yin N; Mei S; Li L; Balfe P; He T; Ba L; Zhang F; Lin HH; Yuen MF; Lai CL; Ho DD
    J Virol; 2004 Dec; 78(24):13591-9. PubMed ID: 15564470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.
    Xia X; Lu L; Tee KK; Zhao W; Wu J; Yu J; Li X; Lin Y; Mukhtar MM; Hagedorn CH; Takebe Y
    J Med Virol; 2008 Jul; 80(7):1142-52. PubMed ID: 18461611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily.
    Vitale F; Villafrate MR; Viviano E; Perna AM; Bonura F; Di Benedetto MA; Mazzola G; Colletti P; Prestileo T; Romano N
    New Microbiol; 1998 Oct; 21(4):335-42. PubMed ID: 9812314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus molecular epidemiology in Uzbekistan.
    Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
    J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemic history of major genotypes of hepatitis C virus in Uruguay.
    Castells M; Bello G; Ifrán S; Pereyra S; Boschi S; Uriarte R; Cristina J; Colina R
    Infect Genet Evol; 2015 Jun; 32():231-8. PubMed ID: 25801607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.
    Beyrer C; Patel Z; Stachowiak JA; Tishkova FK; Stibich MA; Eyzaguirre LM; Carr JK; Mogilnii V; Peryshkina A; Latypov A; Strathdee SA
    AIDS Res Hum Retroviruses; 2009 Sep; 25(9):853-60. PubMed ID: 19689193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China.
    Tao J; Liang J; Zhang H; Pei L; Qian HZ; Chambers MC; Jiang Y; Xiao Y
    PLoS One; 2015; 10(10):e0140263. PubMed ID: 26466103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.